Loading compound...

Small molecule inhibitor

Briciclib is a small molecule being studied for its potential use in treating neoplasms (tumors/cancer). It is currently in the research phase and has not yet been approved for general use.

How it worksBriciclib works by inhibiting specific biological targets associated with the growth of neoplasms.

Used for
Neoplasms (tumors or cancer)
Conditions
Neoplasms
Class
Small moleculeSmall molecule inhibitorNeoplasm/Tumor systems

How to take

This drug is currently in clinical development and is not yet approved by regulatory agencies for specific medical uses.

Talk to your doctor

Questions to ask

  • ·Is Briciclib currently being used in any clinical trials for my condition?
  • ·What stage of research is Briciclib in?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.